Innate Pharma announces its financial calendar for 2012 as well as its participations to upcoming investor conferences

Innate Pharma SA (Euronext Paris: FR0010331421 – IPH), the innate immunity company developing first-in-class drugs for cancer and inflammatory diseases, announces today its tentative financial calendar for 2012.

During the first quarter of 2012, Innate Pharma will participate in the following investor conferences:

• Oddo Midcap Event – Palais des congrès, Lyon, on January 5 & 6, 2012;
• SFAF Biotech Day – SFAF, Paris, on January 20, 2012;
• European Life Science CEO Forum - Hilton Airport Hotel, Zurich, on March 6, 2012.
  During this event, Hervé Brailly, CEO of Innate Pharma, will participate in a panel discussion on “French Public Markets – Breakthrough Technologies”